KEYS vs PRME · P/E 57, rev $4.98B vs rev $3.0M
Keysight Technologies Inc (KEYS) versus Prime Medicine, Inc. Common Stock (PRME) — a side-by-side from cached financials, not a winner call.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Prime Medicine, Inc. Common Stock (PRME) is a biotechnology company listed on NASDAQ.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Latest reported PRME revenue for 2024-12-31 was $3.0M. Net income was -$195.9M. PRME currently screens at market cap $570.8M.
KEYS currently screens at market cap $59.84B and trailing P/E 56.5. PRME currently screens at market cap $570.8M.
Not investment advice. Open the KEYS and PRME stock pages for the full models.
Not investment advice.